Broadly and deeply experienced clinical operations leader with a proven track record of providing strategic oversight to ensure success and mitigate risks across the entire clinical trial process. My comprehensive background encompasses the design, setup, and management of global, Phase 1 (FIH and dose selection) and late-stage clinical trials. From inception to completion, I have actively participated in supporting full clinical development plans, including initial regulatory interactions and iterative protocol. I pride myself on building strong, trust-based relationships with internal and external partners, which is crucial to delivering high-quality outcomes. My deep experience in oncology and immunology focuses on biomarker-selected patient populations, and I possess a robust understanding of the central and specialty laboratory requirements necessary to support global trials. I have successfully supported rare and pediatric studies, alongside managing the esoteric laboratory assays required by these unique clinical programs. My experience also includes leveraging biomarker- and data-driven patient-finding services to support enrollment.A key aspect of my leadership style is the development of high-performing teams through transparent collaboration and open dialogue. I have a proven track record of converting contractors into full-time employees and integrating partner staff as essential team members, fostering an inclusive and effective work environment.I believe strongly in the value of external clinical partnerships, emphasizing bi-directional governance at all levels -- delivery, commercial, quality, and executive. I am recognized for my openness and honesty with partners, always seeking to understand their perspectives and collaboratively find solutions.My understanding of quality oversight, audit processes, CAPA management, and inspection preparation complements my accountability for financial and budgetary considerations at both program and partner levels. I proactively manage business and operational risks to ensure clinical operational excellence while adhering to global regulatory requirements.Driven by a passion for the science underpinning each clinical trial, I am committed to leveraging my knowledge to empower sponsor/partner relationships and enhance the clinical study site experience, ensuring optimal outcomes for all stakeholders involved.